NEUROENDOCRINE TUMORS
Clinical trials for NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug entinostat tested for rare abdominal tumors – study halted early
Disease control TerminatedThis study tested a drug called entinostat in people with advanced abdominal neuroendocrine tumors that had come back or stopped responding to standard treatments. Only 5 people took part, and the study was stopped early. The goal was to see if the drug could shrink tumors or slo…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Promising cancer therapy trial halted after enrolling just one patient
Disease control TerminatedThis study tested whether a radioactive drug called Lutathera, given after surgery to remove liver tumors, could delay cancer from coming back in people with neuroendocrine tumors. Only one person enrolled before the trial was stopped early, so we don't have enough information to…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated May 14, 2026 12:02 UTC